Pierre Fabre is the 2nd largest dermo-cosmetics laboratory in the world and the 2nd largest private French pharmaceutical group. In 2017, it generated 2,318 million euros in revenues, of which 62% came from its international business and 62% from its dermo-cosmetics division. Pierre Fabre, which has always been headquartered in the South-West of France, owns subsidiaries and offices in 47 countries, enjoys distribution agreements in over 130 countries and counts more than 13,500 employees worldwide. 

Pierre Fabre’s portfolio represents a continuum of activities spanning from prescription drugs and consumer health care products to dermo-cosmetics. In 2016, Pierre Fabre dedicated almost 143 million euros to R&D, shared between oncology, the central nervous system, consumer health care, dermatology and dermo-cosmetics.